Fulcrum Therapeutics, Inc.

NASDAQ:FULC

3.56 (USD) • At close November 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Omzet 08000.8710.7590.880.2950.6851.1831.8822.5925.0584.9354.3814.7894.2251.84820.7500000000
Kosten van de omzet 017.2610.4790.5080.50.60.5660.5910.625.0190.5360.62117.07717.37816.33418.86814.86112.77514.4829.8413.49610.8634.6290000
Brutowinst 062.739-0.4790.3630.2590.28-0.2710.0940.583-23.1372.0564.437-12.142-12.997-11.545-14.643-13.013-10.775-13.732-9.84-13.496-10.86-34.6290000
Brutowinstmarge 00.78400.4170.3410.318-0.9190.1370.493-12.2940.7930.877-2.46-2.967-2.411-3.466-7.042-5.388-18.30900000000
Onderzoek- en ontwikkelingskosten 14.63917.26119.29418.99918.23817.84916.71518.56615.36625.01917.83118.91217.07717.37816.33416.14515.6412.77514.48212.08713.49610.8634.6296.866.9635.7885.573
Algemene en administratieve kosten 8.42410.24710.0619.8649.96110.32311.5210.139.70711.09810.7599.7058.6286.6855.4985.8675.3125.1495.0644.4033.512.6342.5982.3912.1252.0611.737
Verkoop- en marketingkosten 000-0.50800000000000000000000000
Verkoop-, algemene en administratieve kosten 8.42410.24710.0619.3569.96110.32311.5210.139.70711.09810.7599.7058.6286.6855.4985.8675.3125.1495.0644.4033.512.6342.5982.3912.1252.0611.737
Overige kosten 2.06302.9643.2363.4233.5093.1611.8380.6170.1650.070.0750.0540.0340.0440.0670.1420.2390.3440.0070.0070.0080.0070.0070.0070.0080.37
Bedrijfskosten 25.12627.50829.35528.35528.19928.17228.23528.69625.07336.11728.5928.61725.70524.06321.83222.01220.95217.92419.54616.4917.00613.49437.2279.2519.0887.8497.31
Bedrijfsresultaat -25.12652.492-29.834-27.992-27.44-27.292-27.94-27.973-24.355-34.235-25.998-23.559-20.77-19.682-17.043-17.787-19.104-15.924-18.796-16.49-17.006-13.494-37.227-9.251-9.088-7.849-7.31
Bedrijfsresultaat ratio 00.6560-32.138-36.153-31.014-94.712-40.836-20.587-18.191-10.03-4.658-4.209-4.493-3.559-4.21-10.338-7.962-25.06100000000
Totaal overige inkomsten en kosten netto 3.432.9172.9643.2363.4233.5093.1611.8380.6170.1650.070.0750.0540.0340.0440.0670.1420.2390.3440.3670.4640.3250.3840.3920.1450.0030.37
Inkomen voor belasting -21.69655.409-26.87-24.756-24.017-23.783-24.779-26.135-23.738-34.07-25.928-23.484-20.716-19.648-16.999-17.72-18.962-15.685-18.452-16.123-16.542-13.169-36.843-8.859-8.943-7.846-6.94
Inkomen voor belasting ratio 00.6930-28.423-31.643-27.026-83.997-38.153-20.066-18.103-10.003-4.643-4.198-4.485-3.55-4.194-10.261-7.843-24.60300000000
Belastingkosten 000.4353.1610.4090.525-3.161-2.5050.313-0.024-0.07-0.6210.019-0.0280-0.733000-0.879-0.457-0.317-0.377-0.385-0.1380.0050
Nettowinst -21.69655.409-26.87-24.756-24.017-23.783-21.618-23.63-24.051-34.07-25.858-23.484-20.716-19.648-16.999-17.72-18.962-15.685-18.452-16.123-16.542-13.169-36.843-8.859-8.943-7.846-6.94
Nettowinstmarge 00.6930-28.423-31.643-27.026-73.281-34.496-20.331-18.103-9.976-4.643-4.198-4.485-3.55-4.194-10.261-7.843-24.60300000000
WPA (Winst Per Aandeel) -0.350.89-0.43-0.4-0.39-0.38-0.36-0.45-0.52-0.83-0.64-0.58-0.57-0.6-0.54-0.64-0.7-0.66-0.81-0.71-0.93-0.56-1.58-0.52-0.53-0.46-0.41
Verwaterde WPA -0.350.87-0.43-0.4-0.39-0.38-0.36-0.45-0.52-0.83-0.64-0.58-0.57-0.6-0.54-0.64-0.7-0.66-0.81-0.71-0.93-0.56-1.58-0.52-0.53-0.46-0.41
EBITDA -25.12655.809-29.355-27.484-26.909-26.725-27.374-27.42-23.279-33.559-25.462-22.938-20.151-19.01-16.44-17.054-18.55-15.371-18.257-15.971-16.49-12.98-36.723-8.742-8.629-7.646-7.136
EBITDA ratio 00.6560-31.555-35.453-30.369-94.712-40.947-19.285-17.832-9.823-4.658-4.083-4.339-3.433-4.21-10.038-7.686-24.34300000000